Elabscience

PSCA Polyclonal Antibody

Product Code:
 
E-AB-53288
Product Group:
 
Primary Antibodies
Supplier:
 
Elabscience
Host Type:
 
Rabbit
Antibody Isotype:
 
IgG
Antibody Clonality:
 
Polyclonal
Regulatory Status:
 
RUO
Target Species:
  • Human
  • Mouse
Applications:
  • Enzyme-Linked Immunosorbent Assay (ELISA)
  • Immunohistochemistry (IHC)
  • Western Blot (WB)
Shipping:
 
Ice packs
Storage:
 
Store at -20°C. Avoid freeze / thaw cycles.
1 / 2
Western blot analysis of Mouse heart tissue Mouse stomach tissue and PC-3 cell lysates  using PSCA Polyclonal Antibody at dilution of 1:650
2 / 2
Immunohistochemistry of paraffin-embedded Human tonsil tissue  using PSCA Polyclonal Antibody at dilution of 1:25(?200)

Western blot analysis of Mouse heart tissue Mouse stomach tissue and PC-3 cell lysates  using PSCA Polyclonal Antibody at dilution of 1:650
Immunohistochemistry of paraffin-embedded Human tonsil tissue  using PSCA Polyclonal Antibody at dilution of 1:25(?200)

No additional charges, what you see is what you pay! *

CodeSizePrice
E-AB-53288-20uL20uL£125.00
Quantity:
E-AB-53288-60uL60uL£172.00
Quantity:
E-AB-53288-120uL120uL£237.00
Quantity:
E-AB-53288-200uL200uL£344.00
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: China.
Typical lead time: 14-21 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • Show All

Further Information

Abbreviation:
PSCA
Background:
PSCA (Prostate Stem Cell antigen) is a cell surface antigen, which is overexpressed in ~40% of primary prostate cancers and in as many as 100% of metastatic ones. PSCA is also overexpressed in a majority of transitional cell and pancreatic carcinomas. Antibody directed against PSCA inhibits tumorigenesis, slows tumor growth, prolongs survival and prevents metastasis in a preclinical zenograft model indicating that PSCA may have utility as a prognostic marker and/or therapeutic target in prostate cancer.
Buffer:
PBS with 0.05% NaN3 and 40% Glycerol,pH7.4
Calculated MW:
13 kDa
Concentration:
0.78 mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000, IHC 1:20-1:100, ELISA 1:5000-1:10000
Immunogen:
Synthetic peptide of human PSCA
ObservedMW:
Refer to figures
Purification method:
Antigen affinity purification
Target Synonym:
PRO 232;PRO232;Prostate stem cell antigen
UNIProt ID:
O43653

Documents